Synthesis of 2-(4-Substitutedbenzyl-[1,4]Diazepan-1-yl)-N-(1-Methyl-4,5-Dihydro-[1,2,4]Triazolo[4,3-A]Quinolin-7-Yl)Acetamides as Inotropic Agents

Chemical Biology and Drug Design

Volumn 77, Issue 1, 2011, Pages 98-103

  Ye, Bai Jun ^a   Liu, Xue Kun ^a   Jiang, Sheng Ming ^a   Cui, Xun ^a   Piao, Hu Ri ^a  

^a YANBIAN UNIVERSITY   (China)

Author keywords

1,4 diazepan; 1,2,4 triazolo 4,3 a quinolines; Positive inotropic activity; Stroke volume

Indexed keywords

2[4 (4 METHYLBENZYL) [1,4]DIAZEPAN 1 YL] N (4,5 DIHYDRO 1 METHYL[1,2,4]TRIAZOLO[4,3 A]QUINOLIN 7 YL)ACETAMIDE; INOTROPIC AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHRONOTROPISM; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; HEART STROKE VOLUME; INOTROPISM; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

ACETAMIDES; ANIMALS; AZEPINES; CARDIOTONIC AGENTS; HEART; MILRINONE; MYOCARDIAL CONTRACTION; ORGAN CULTURE TECHNIQUES; RABBITS; STROKE VOLUME; TRIAZOLES;

ORYCTOLAGUS CUNICULUS;

EID: 78650156805     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2010.01057.x     Document Type: Article

References (10)

1. The Digitalis Investigation Group. (1997) The Effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med;336:525-533.
2. Takafumi F., Shuji T., Toyoki M., Tetsumi H., Takumi S., Michiaki T., Youich Y. (1992) Novel positive inotropic agents: synthesis and biological activities of 6-(3-amino-2-hydroxypropoxy)-2(1H)-quinolinone derivatives. J Med Chem;35:3607-3612.
3. Packer M., Carver J.R., Rodeheffer R.J., Ivanhoe R.J., DiBianco R., Zeldis S.M., Hendrix G.H., Bommer W.J., Elkayam U., Kukin M.L. (1991) Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med;325:1468-1475.
4. Cohn J.N., Goldstein S.O., Greenberg B.H., Lorell B.H., Bourge R.C., Jaski B.E., Gottlieb S.O., McGrew F., DeMets D.L., White B.G. (1998) A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure. N Engl J Med;339:1810-1816.
5. Harada K., Supriatno E., Yoshida H., Sato M. (2005) Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8. Int J Oncol;27:1489-1497.
6. Piao H.R., Quan Z.S., Xu M.X., Deng D.W. (1999) Synthesis and positive inotropic activities of 3, 4-dihydro-6-(4-substituted-1-piperazinylacetamino)-2(1H)-quinolinone derivatives. Chinese J Med Chem;9:79-83.
7. Lee S.J., Kim S.Z., Cui X., Kim S.H., Lee K.S., Chung Y.J., Cho K.W. (2000) C-type natriuretic peptide inhibits ANP secretion and atrial dynamics in perfused atria: NPR-B-cGMP signaling. Am J Physiol Heart Circ Physiol;278:208-221.
8. 2+-independent cAMP inhibition of ANP release in beating rabbit atria. Am J Physiol Regul Integr Comp Physiol;282:1477-1489.
9. Zhang C.B., Piao H.R. (2002) Synthesis of 4, 5-dihydro-[1, 2, 4]Triazolo[4, 3-a]quinolin derivatives. Chem Res & Appl;5:618-619.
10. Liao X.C. (1993) Synthesis of phenyl(piperazin-1-yl)methanone. Chin J Pharm;1:21-22.